Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;29(1):237-41.
doi: 10.1038/leu.2014.261. Epub 2014 Sep 3.

Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis

J H Schatz  1 , S M Horwitz  2 , J Teruya-Feldstein  3 , M A Lunning  2 , A Viale  4 , K Huberman  4 , N D Socci  5 , N Lailler  4 , A Heguy  6 , I Dolgalev  6 , J C Migliacci  2 , M Pirun  5 , M L Palomba  2 , D M Weinstock  7 , H-G Wendel  8
Affiliations

Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis

J H Schatz et al. Leukemia. 2015 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of mutations in 28 diagnostic peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) cases. Included are all genes affected in multiple cases, or those affected in single cases with mutations listed in COSMIC or other reports as indicated in Table 1. Nodal: original presentation as nodal disease (black boxes) vs original extranodal presentation (white boxes).
See this image and copyright information in PMC

References

    1. Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, et al. Gene expression signatures delineate biologic and prognostic subgroups in peripheral T-cell lymphoma. Blood. 2014;123:2915–2923. - PMC - PubMed
    1. Vose J, Armitage J, Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124–4130. - PubMed
    1. Cairns RA, Iqbal J, Lemonnier F, Kucuk C, de Leval L, Jais JP, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119:1901–1903. - PMC - PubMed
    1. Palomero T, Couronné L, Khiabanian H, Kim M-Y, Ambesi-Impiombato A, Perez-Garcia A, et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014;46:166–170. - PMC - PubMed
    1. Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46:171–175. - PubMed

Publication types